cyh33
Small moleculeexperimental
Clinical trial activity
5 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
4
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started May 17, 2018 (NCT03544905)
Timeline
Indications
Mechanism of action
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06975618 | Phase 1/Phase 2 (Phase 2) | Aug 22, 2023 | ShangHai HaiHe Pharmaceutical |
| NCT05043922 | Phase 2 | Sep 9, 2021 | ShangHai HaiHe Pharmaceutical |
| NCT04856371 | Phase 1 | Apr 30, 2021 | ShangHai HaiHe Pharmaceutical |
| NCT04586335 | Phase 1 | Sep 28, 2020 | ShangHai HaiHe Pharmaceutical |
| NCT03544905 | Phase 1 | May 17, 2018 | ShangHai HaiHe Pharmaceutical, Sun Yat-Sen University |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| ShangHai HaiHe Pharmaceutical | For profit | 5 | 5 | 2 | 2018 |
| Sun Yat-Sen University | Academic/Hospital | 1 | 0 | 1 | 2018 |
2 organizations
Page 1 / 1